Treatment of Withdrawal Symptoms With NADA Acupuncture in Chronic Pain Patients
NCT03397212 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2018-01-11
Summary
This project aims at examining the following hypotheses:
* Treatment with NADA and clonidine reduces intensity of withdrawal symptoms to a greater extent than treatment with clonidine.
* Opioid withdrawal improves pain, physical and mental functioning and reduces opioid consumption 3 months and 1 year after withdrawal.
Conditions
- Chronic Pain
- Opiate Withdrawal Syndrome
Interventions
- OTHER
-
NADA acupuncture
Ear acupuncture protocol described by National Acupuncture Detoxification Association
- OTHER
-
Sham acupuncture
Ear acupuncture using inactive sham points
Sponsors & Collaborators
-
Rigshospitalet, Denmark
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-01-15
- Primary Completion
- 2022-01-15
- Completion
- 2024-01-15
Countries
- Denmark
Study Locations
More Related Trials
-
Pilot Research on Opioid Use Disorder
NCT04244227 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Light Needle for Opioid Use Disorder
NCT05341219 ·Status: UNKNOWN ·Phase: NA
-
Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1
NCT00238914 ·Status: COMPLETED ·Phase: PHASE2
-
Addition of Naltrexone to Methadone Taper
NCT00135759 ·Status: COMPLETED ·Phase: PHASE2
-
Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2
NCT00000299 ·Status: COMPLETED ·Phase: PHASE2
-
Employment-based Reinforcement of Naltrexone Ingestion and Abstinence
NCT00149669 ·Status: COMPLETED ·Phase: NA
-
Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal
NCT04075214 ·Status: COMPLETED ·Phase: NA
-
Opiate Craving Reduction Study Using Post-detox Patients on Suboxone and Use of TEAS as Adjunctive Treatment
NCT02033746 ·Status: WITHDRAWN ·Phase: NA
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3
NCT00000328 ·Status: WITHDRAWN ·Phase: PHASE2
-
Evaluation of a Physical Device for Medical Use (ADTPM 1) for Opioid Withdrawal Symptoms
NCT07079215 ·Status: RECRUITING ·Phase: NA
-
Study of the Treatment of Experimental Pain in Buprenorphine Maintained Persons With Chronic Musculoskeletal Pain
NCT02372591 ·Status: COMPLETED ·Phase: PHASE1
-
Behavioral Naltrexone Therapy: A Novel Treatment for Heroin Dependence
NCT00332228 ·Status: COMPLETED ·Phase: PHASE2
-
Tapering From Long-term Opioid Therapy in Chronic Pain Population. Randomized Controlled Trial With 12 Months Follow up
NCT03485430 ·Status: COMPLETED ·Phase: NA
-
Study of the Treatment of Experimental Pain in Opioid Dependent Persons on Methadone or Buprenorphine Maintenance
NCT01642030 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of Buprenorphine/Naloxone
NCT02882412 ·Status: UNKNOWN
-
Pilot Trial of Opioid Taper Support
NCT01883882 ·Status: COMPLETED ·Phase: NA
-
Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence
NCT00134888 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate Withdrawal Effects Following Dosing of Oxycodone/Naltrexone in Methadone-Maintained Subjects
NCT02391571 ·Status: COMPLETED ·Phase: PHASE3
-
Dronabinol Naltrexone Treatment for Opioid Dependence
NCT01024335 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1
NCT00032968 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Opioid Taper on Opioid-Induced Hyperalgesia
NCT03063905 ·Status: TERMINATED
-
The Impact of Co-Dispensing Naloxone to Patients Prescribed Chronic Opioid Therapy
NCT03337100 ·Status: COMPLETED ·Phase: NA
-
Methadone Hydrochloride as First-Line Therapy in Treating Patients With Chronic Neuropathic Cancer Pain
NCT00930332 ·Status: TERMINATED ·Phase: PHASE1
-
Biomarkers of Injectable Extended Release Naltrexone Treatment
NCT02324725 ·Status: COMPLETED ·Phase: PHASE4
-
Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone
NCT00577408 ·Status: COMPLETED ·Phase: PHASE3